Carboplatin Market, By Indication (Ovarian cancer, Small cell lung cancer and Others) and by Region (North America, Europe, Asia Pacific and RoW) Analysis, Share, Trends, Size, & Forecast From 2014 2025
The carboplatin market is estimated to represent a global market of USD xx billion by 2017 with growth rate of xx%.
Carboplatin is used in treatment of ovarian cancer as well as many other cancers such as small cell lung cancer, breast cancer, germ cell tumours. During the treatment, in some cases the cancer becomes resistant to carboplatin and other platinum based drugs such as Cis Platin. This condition is known as platinum resistant cancer. Pipeline studies are being conducted in which other drugs are used to bring back sensitivity of cancer to platinum based drugs.
Indication Takeaway
Ovarian cancer dominates the global carboplatin market over the forecast period. Increase in reoccurrence rate of ovarian cancer is expected to boost the market for carboplatin, as many medical practitioners preferred chemo therapy over surgery and radiation therapy. Furthermore, carboplatin more tolerable in geriatric patients compared to its counterpart and is more effective than carboplatin which in turn may increase the market for carboplatin in the study period. Increasing use of carboplatin to treat other form of cancer such as breast and lung is expected to propel the market for carboplatin in near future.
Regional Takeaway
In terms of revenue, Asia Pacific held the larger market share in 2016. Increasing incidence of cancer, increase in healthcare spending and growing contract manufacturing service in the region owing to low cost of manufacturing are the main factor driving the growth of carboplatin market over the forecast period. Moreover, presence of favorable government initiatives and increase in contract research and development service in China and India is expected to boost the market for carboplatin in the region.
Key Vendor Takeaway
- Johnson Metthey
- Heraeus Group
- Tecoland Corporation
- Qilu Pharmaceutical Company
- Mylan, Inc.
- Taj Pharmaceuticals
- Umicore
- Teva Pharmaceutical
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2014 & 2016
- Base Year – 2017
- Estimated Year – 2018
- Projected Year – 2025
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies
- Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY INDICATION
- Ovarian cancer
- Small cell lung cancer
- Others
MARKET, BY REGION
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Rest of Europe
- Asia Pacific
- India
- China
- Rest of APAC
- Rest of the World
- Middle East and Africa
- Latin America
TABLE OF CONTENT
1. CARBOPLATIN MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. CARBOPLATIN KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. CARBOPLATIN INDUSTRY STUDY
4.1. Porter’s Analysis
4.2. Market Attractiveness Analysis
4.3. Raw Material Analysis
4.3.1. Wheat
4.3.2. Potato
4.3.3. Corn
4.3.4. Cassava
4.4. Technology Overview
4.5. Regulatory Framework Analysis
5. CARBOPLATIN MARKET LANDSCAPE
5.1. Market Share Analysis
6. CARBOPLATIN MARKET – BY INDICATION
6.1. Overview
6.1.1. Overview
6.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.2. Ovarian cancer
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.3. Small cell lung cancer
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.4. Others
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7. CARBOPLATIN MARKET– BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.2.3. U.S.
7.2.3.1. Overview
7.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.2.4. Canada
7.2.4.1. Overview
7.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.3. Europe
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.3.3. France
7.3.3.1. Overview
7.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.3.4. Germany
7.3.4.1. Overview
7.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.3.5. Rest of Europe
7.3.5.1. Overview
7.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.4. Asia Pacific (APAC)
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.4.3. China
7.4.3.1. Overview
7.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.4.4. India
7.4.4.1. Overview
7.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.4.5. Rest of APAC
7.4.5.1. Overview
7.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.5. Rest of the World
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.5.3. Latin America
7.5.3.1. Overview
7.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.5.4. Middle East and Africa
7.5.4.1. Overview
7.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8. KEY VENDOR ANALYSIS
8.1. Johnson Metthey
8.1.1. Company Overview
8.1.2. SWOT Analysis
8.1.3. Key Developments
8.2. Heraeus Group
8.2.1. Company Overview
8.2.2. SWOT Analysis
8.2.3. Key Developments
8.3. Tecoland Corporation
8.3.1. Company Overview
8.3.2. SWOT Analysis
8.3.3. Key Developments
8.4. Qilu Pharmaceutical Company
8.4.1. Company Overview
8.4.2. SWOT Analysis
8.4.3. Key Developments
8.5. Mylan
8.5.1. Company Overview
8.5.2. SWOT Analysis
8.5.3. Key Developments
8.6. Taj Pharmaceuticals
8.6.1. Company Overview
8.6.2. SWOT Analysis
8.6.3. Key Developments
8.7. Umicore
8.7.1. Company Overview
8.7.2. SWOT Analysis
8.7.3. Key Developments
8.8. Teva Pharmaceutical
8.8.1. Company Overview
8.8.2. SWOT Analysis
8.8.3. Key Developments
9. 360 DEGREE ANALYSTVIEW
10. APPENDIX
10.1. Research Methodology
10.2. Abbreviations
10.3. Disclaimer
10.4. Contact Us
List of Tables
Table 1 List of Acronyms
Table 2 Key Market Facts, 2014 – 2025
Table 3 Market Drivers: Impact Analysis
Table 4 Market Restraint: Impact Analysis
Table 5 Market Opportunity: Impact Analysis
Table 6 PEST Analysis
Table 7 Porter’s Five Forces Analysis
Table 8 Company Market Share Analysis
Table 9 Global Carboplatin Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
Table 10 Carboplatin Market, by Indication, 2014 – 2025 (USD Billion)
Table 12 Carboplatin Market, by Geography, 2014 – 2025 (USD Billion)
Table 13 North America Carboplatin Market, 2014 – 2025 (USD Billion)
Table 14 U.S. Carboplatin Market, 2014 – 2025 (USD Billion)
Table 15 Canada Carboplatin Market, 2014 – 2025 (USD Billion)
Table 16 Europe Carboplatin Market, 2014 – 2025 (USD Billion)
Table 17 France Carboplatin Market, 2014 – 2025 (USD Billion)
Table 18 Germany Carboplatin Market, 2014 – 2025 (USD Billion)
Table 19 Asia Pacific Carboplatin Market, 2014 – 2025 (USD Billion)
Table 20 China Carboplatin Market, 2014 – 2025 (USD Billion)
Table 21 India Carboplatin Market, 2014 – 2025 (USD Billion)
Table 22 Latin America Carboplatin Market, 2014 – 2025 (USD Billion)
Table 23 MEA Carboplatin Market, 2014 – 2025 (USD Billion)
List of Figures
Figure 1 Research Methodology
Figure 2 Research Process Flow Chart
Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
Figure 4 Value Chain Analysis
Figure 5 Carboplatin Market, by Indication, 2014 – 2025 (USD Billion)
Figure 6 Carboplatin Market, by Geography, 2014 – 2025 (USD Billion)
